159 related articles for article (PubMed ID: 34322687)
21. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
[TBL] [Abstract][Full Text] [Related]
22. Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target Protein.
Choi S; Joo HK; Jeon BH
Chonnam Med J; 2016 May; 52(2):75-80. PubMed ID: 27231670
[TBL] [Abstract][Full Text] [Related]
23. The anti-inflammatory role of extranuclear apurinic/apyrimidinic endonuclease 1/redox effector factor-1 in reactive astrocytes.
Baek H; Lim CS; Byun HS; Cho HS; Lee YR; Shin YS; Kim HW; Jeon BH; Kim DW; Hong J; Hur GM; Park JB
Mol Brain; 2016 Dec; 9(1):99. PubMed ID: 27986089
[TBL] [Abstract][Full Text] [Related]
24. In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer.
Mijit M; Kpenu E; Chowdhury NN; Gampala S; Wireman R; Liu S; Babb O; Georgiadis MM; Wan J; Fishel ML; Kelley MR
Redox Biol; 2024 Feb; 69():102977. PubMed ID: 38056311
[TBL] [Abstract][Full Text] [Related]
25. New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.
Gampala S; Moon HR; Wireman R; Peil J; Kiran S; Mitchell DK; Brewster K; Mang H; Masters A; Bach C; Smith-Kinnamen W; Doud EH; Rai R; Mosley AL; Quinney SK; Clapp DW; Hamdouchi C; Wikel J; Zhang C; Han B; Georgiadis MM; Kelley MR; Fishel ML
Pharmacol Res; 2024 Mar; 201():107092. PubMed ID: 38311014
[TBL] [Abstract][Full Text] [Related]
26. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract][Full Text] [Related]
27. DNA repair and redox activities and inhibitors of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1): a comparative analysis and their scope and limitations toward anticancer drug development.
Kaur G; Cholia RP; Mantha AK; Kumar R
J Med Chem; 2014 Dec; 57(24):10241-56. PubMed ID: 25280182
[TBL] [Abstract][Full Text] [Related]
28. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?
Tell G; Damante G; Caldwell D; Kelley MR
Antioxid Redox Signal; 2005; 7(3-4):367-84. PubMed ID: 15706084
[TBL] [Abstract][Full Text] [Related]
29. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
[TBL] [Abstract][Full Text] [Related]
30. Anticancer clinical utility of the apurinic/apyrimidinic endonuclease/redox factor-1 (APE/Ref-1).
Zhang Y; Wang J
Chin J Cancer; 2010 Mar; 29(3):333-9. PubMed ID: 20193121
[TBL] [Abstract][Full Text] [Related]
31. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (Ape1/Ref-1) Modulates Antigen Presenting Cell-mediated T Helper Cell Type 1 Responses.
Akhter N; Takeda Y; Nara H; Araki A; Ishii N; Asao N; Asao H
J Biol Chem; 2016 Nov; 291(45):23672-23680. PubMed ID: 27637330
[TBL] [Abstract][Full Text] [Related]
32. Endonuclease and redox activities of human apurinic/apyrimidinic endonuclease 1 have distinctive and essential functions in IgA class switch recombination.
Frossi B; Antoniali G; Yu K; Akhtar N; Kaplan MH; Kelley MR; Tell G; Pucillo CEM
J Biol Chem; 2019 Mar; 294(13):5198-5207. PubMed ID: 30705092
[TBL] [Abstract][Full Text] [Related]
33. Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1.
Kelley MR; Parsons SH
Antioxid Redox Signal; 2001 Aug; 3(4):671-83. PubMed ID: 11554453
[TBL] [Abstract][Full Text] [Related]
34. Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells.
Champion JD; Dodd KM; Lam HC; Alzahrani MAM; Seifan S; Rad E; Scourfield DO; Fishel ML; Calver BL; Ager A; Henske EP; Davies DM; Kelley MR; Tee AR
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551683
[TBL] [Abstract][Full Text] [Related]
35. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
[TBL] [Abstract][Full Text] [Related]
36. RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostasis in Mouse PDAC Cells.
Mijit M; Wireman R; Armstrong L; Gampala S; Hassan Z; Schneeweis C; Schneider G; Zhang C; Fishel ML; Kelley MR
Front Oncol; 2022; 12():826617. PubMed ID: 35402225
[TBL] [Abstract][Full Text] [Related]
37. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
38. Beyond VEGF: Targeting Inflammation and Other Pathways for Treatment of Retinal Disease.
Muniyandi A; Hartman GD; Song Y; Mijit M; Kelley MR; Corson TW
J Pharmacol Exp Ther; 2023 Jul; 386(1):15-25. PubMed ID: 37142441
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of stimulation of DNA binding of the transcription factors by human apurinic/apyrimidinic endonuclease 1, APE1.
Bazlekowa-Karaban M; Prorok P; Baconnais S; Taipakova S; Akishev Z; Zembrzuska D; Popov AV; Endutkin AV; Groisman R; Ishchenko AA; Matkarimov BT; Bissenbaev A; Le Cam E; Zharkov DO; Tudek B; Saparbaev M
DNA Repair (Amst); 2019 Oct; 82():102698. PubMed ID: 31518879
[TBL] [Abstract][Full Text] [Related]
40. The Biological Role of Apurinic/Apyrimidinic Endonuclease1/Redox Factor-1 as a Therapeutic Target for Vascular Inflammation and as a Serologic Biomarker.
Lee YR; Joo HK; Jeon BH
Biomedicines; 2020 Mar; 8(3):. PubMed ID: 32164272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]